Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker HCAT
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | Benjamin Landry General Counsel | HCAT Health Catalyst, Inc | Sale | 29,478 | $1.39 | $41.0K Sale | Form 4 ↗ |
| Nov 11, 2026 | Benjamin Landry General Counsel | HCAT Health Catalyst, Inc | Sale | 70,000 | $1.43 | $100.0K Sale | Form 4 ↗ |
| Sep 14, 2026 | Simeon Kohl Chief Executive Officer, Director | HCAT Health Catalyst, Inc | Buy | 59,000 | $1.79 | $105.6K Buy | Form 4 ↗ |
| Dec 5, 2025 | Benjamin Landry General Counsel | HCAT Health Catalyst, Inc | Sale | 27,425 | $2.64 | $72.4K Sale | Form 4 ↗ |
| Dec 4, 2025 | Julie Larson-Green Director | HCAT Health Catalyst, Inc | Sale | 47,997 | $2.67 | $128.2K Sale | Form 4 ↗ |
| Sep 5, 2025 | Benjamin Landry General Counsel | HCAT Health Catalyst, Inc | Sale | 6,175 | $3.35 | $20.7K Sale | Form 4 ↗ |
| Jun 5, 2025 | Benjamin Landry General Counsel | HCAT Health Catalyst, Inc | Sale | 6,057 | $3.94 | $23.9K Sale | Form 4 ↗ |
| May 5, 2025 | Daniel LeSueur Chief Operating Officer | HCAT Health Catalyst, Inc | Sale | 5,209 | $4.10 | $21.4K Sale | Form 4 ↗ |
| Apr 3, 2025 | Daniel LeSueur Chief Operating Officer | HCAT Health Catalyst, Inc | Sale | 5,209 | $4.15 | $21.6K Sale | Form 4 ↗ |
| Mar 6, 2025 | Benjamin Landry General Counsel | HCAT Health Catalyst, Inc | Sale | 13,827 | $4.55 | $62.9K Sale | Form 4 ↗ |
| Mar 5, 2025 | Daniel LeSueur Chief Operating Officer | HCAT Health Catalyst, Inc | Sale | 16,902 | $4.52 | $76.4K Sale | Form 4 ↗ |
| Feb 18, 2025 | Linda Llewelyn Chief People Officer | HCAT Health Catalyst, Inc | Sale | 6,441 | $5.43 | $35.0K Sale | Form 4 ↗ |
| Feb 5, 2025 | Daniel LeSueur Chief Operating Officer | HCAT Health Catalyst, Inc | Sale | 5,209 | $5.76 | $30.0K Sale | Form 4 ↗ |
| Jan 15, 2025 | Linda Llewelyn Chief People Officer | HCAT Health Catalyst, Inc | Sale | 6,442 | $5.80 | $37.4K Sale | Form 4 ↗ |
| Jan 6, 2025 | Daniel LeSueur Chief Operating Officer | HCAT Health Catalyst, Inc | Sale | 5,209 | $7.51 | $39.1K Sale | Form 4 ↗ |
| Jan 6, 2025 | Benjamin Landry General Counsel | HCAT Health Catalyst, Inc | Sale | 2,500 | $7.52 | $18.8K Sale | Form 4 ↗ |
| Dec 30, 2024 | Duncan Gallagher Director | HCAT Health Catalyst, Inc | Sale | 4,500 | $6.93 | $31.2K Sale | Form 4 ↗ |
| Dec 23, 2024 | Duncan Gallagher Director | HCAT Health Catalyst, Inc | Sale | 4,500 | $6.98 | $31.4K Sale | Form 4 ↗ |
| Dec 16, 2024 | Linda Llewelyn Chief People Officer | HCAT Health Catalyst, Inc | Sale | 6,442 | $7.88 | $50.8K Sale | Form 4 ↗ |
| Dec 6, 2024 | Jason Alger Chief Financial Officer | HCAT Health Catalyst, Inc | Sale | 19,599 | $8.32 | $163.1K Sale | Form 4 ↗ |
| Dec 6, 2024 | Benjamin Landry General Counsel | HCAT Health Catalyst, Inc | Sale | 19,268 | $8.32 | $160.3K Sale | Form 4 ↗ |
| Dec 4, 2024 | Daniel LeSueur Chief Operating Officer | HCAT Health Catalyst, Inc | Sale | 22,773 | $7.70 | $175.4K Sale | Form 4 ↗ |
| Dec 2, 2024 | Kevin Lee Freeman Chief Commercial Officer | HCAT Health Catalyst, Inc | Sale | 7,500 | $8.94 | $67.0K Sale | Form 4 ↗ |
| Nov 15, 2024 | Linda Llewelyn Chief People Officer | HCAT Health Catalyst, Inc | Sale | 1,365 | $8.50 | $11.6K Sale | Form 4 ↗ |
| Nov 5, 2024 | Daniel LeSueur Chief Operating Officer | HCAT Health Catalyst, Inc | Sale | 5,209 | $7.70 | $40.1K Sale | Form 4 ↗ |
| Oct 15, 2024 | Linda Llewelyn Chief People Officer | HCAT Health Catalyst, Inc | Sale | 1,324 | $8.16 | $10.8K Sale | Form 4 ↗ |
| Oct 3, 2024 | Daniel LeSueur Chief Operating Officer | HCAT Health Catalyst, Inc | Sale | 5,209 | $7.68 | $40.0K Sale | Form 4 ↗ |
27 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:23 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances